Back to EGRX

EAGLE PHARMACEUTICALS, INC. 8-K

Accession 0001104659-24-105232

Filing information

CIK
0000827871
Report date
2024-09-27
Filing date
2024-10-02
Form
8-K
Primary document
tm2425306d1_8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.